Featured Research

from universities, journals, and other organizations

Experimental Antibiotic Promptly Kills Drug-Resistant Bacteria In Studies

Date:
February 1, 1999
Source:
Brown University
Summary:
Brown University studies show that an experimental antibiotic promptly kills six strains of drug-resistant bacteria that cause respiratory tract infections, and that, at an equal dose, the antibiotic is more effective than an antibiotic now in use against different breeds of drug-resistant bacteria that cause staph infections, gastrointestinal illnesses or pneumonia.

PROVIDENCE, R.I. -- Brown University studies show that an experimental antibiotic promptly kills six strains of drug-resistant bacteria that cause respiratory tract infections, and that, at an equal dose, the antibiotic is more effective than an antibiotic now in use against different breeds of drug-resistant bacteria that cause staph infections, gastrointestinal illnesses or pneumonia.

The experimental drug is called moxifloxacin. The findings suggest it is a potential treatment against a range of drug-resistant infectious organisms that produce serious, even deadly illnesses. Resistance to penicillin and other antibiotics is increasing worldwide among bacterial strains.

A research team used lab tests to show that a single 400-mg moxifloxacin dose is enough to quickly kill six strains of Streptococcus pneumoniae, with no regrowth. The strains killed included those resistant to the antibiotics penicillin and erythromycin. Respiratory tract illnesses caused by Streptococcus pneumoniae are among the leading types of bacterial infections in many countries.

"The findings suggest that moxifloxacin should be useful in treating infections caused by Streptococcus pneumoniae bacteria, which are susceptible to treatment with, yet resistant to, penicillin and erythromycin," said Stephen Zinner, M.D., professor of medicine. Clinical trials are needed to confirm these findings, he said.

Zinner presented the results last October at the Interscience Conference on Antimicrobial Agents and Chemotherapy.

In November, at the Sixth International Symposium on New Quinolones and Related Antibiotics, Zinner reported that moxifloxacin, at equal doses, was more effective against different strains of resistant bacteria that cause staph infections, gastrointestinal illnesses or pneumonia than the antibiotic levofloxacin, currently used to treat a range of infections.

These new findings about moxifloxacin are not necessary for it to become licensed but are used to determine optimal dose and may help in clinical-trial design, said Zinner, head of the Division of Infectious Diseases at Roger Williams Medical Center and Rhode Island Hospital.

The research employed a two-section lab model created in collaboration with Alexander Firsov and colleagues at the Centre of Science and Technology (LekBioTech) in Moscow. The model's external compartment features a series of tubing-linked chambers that house bacteria. This peripheral structure communicates with a central compartment into which antibiotic is infused.

The design allows researchers to periodically vary the concentration of antibiotics in contact with the bacteria, simulating the half-life of a drug being absorbed, distributed and eliminated in the human body.

"Changing the concentrations mimics the pharmacokinetic profile in patients," Zinner said. "Comparing activities of new drugs against old drugs based on pharmacokinetic considerations allows us to end up with a better idea of the dose of the new drug that gives the same effect as that of the old drug."

In November, the model was described in two papers in the journal Antimicrobial Agents and Chemotherapy.


Story Source:

The above story is based on materials provided by Brown University. Note: Materials may be edited for content and length.


Cite This Page:

Brown University. "Experimental Antibiotic Promptly Kills Drug-Resistant Bacteria In Studies." ScienceDaily. ScienceDaily, 1 February 1999. <www.sciencedaily.com/releases/1999/02/990201073352.htm>.
Brown University. (1999, February 1). Experimental Antibiotic Promptly Kills Drug-Resistant Bacteria In Studies. ScienceDaily. Retrieved August 28, 2014 from www.sciencedaily.com/releases/1999/02/990201073352.htm
Brown University. "Experimental Antibiotic Promptly Kills Drug-Resistant Bacteria In Studies." ScienceDaily. www.sciencedaily.com/releases/1999/02/990201073352.htm (accessed August 28, 2014).

Share This




More Health & Medicine News

Thursday, August 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Treadmill 'trips' May Reduce Falls for Elderly

Treadmill 'trips' May Reduce Falls for Elderly

AP (Aug. 28, 2014) Scientists are tripping the elderly on purpose in a Chicago lab in an effort to better prevent seniors from falling and injuring themselves in real life. (Aug.28) Video provided by AP
Powered by NewsLook.com
Mini Pacemaker Has No Wires

Mini Pacemaker Has No Wires

Ivanhoe (Aug. 27, 2014) Cardiac experts are testing a new experimental device designed to eliminate major surgery and still keep the heart on track. Video provided by Ivanhoe
Powered by NewsLook.com
After Cancer: Rebuilding Breasts With Fat

After Cancer: Rebuilding Breasts With Fat

Ivanhoe (Aug. 27, 2014) More than 269 million women are diagnosed with breast cancer each year. Many of them will need surgery and radiation, but there’s a new simple way to reconstruct tissue using a patient’s own fat. Video provided by Ivanhoe
Powered by NewsLook.com
Blood Clots in Kids

Blood Clots in Kids

Ivanhoe (Aug. 27, 2014) Every year, up to 200,000 Americans die from a blood clot that travels to their lungs. You’ve heard about clots in adults, but new research shows kids can get them too. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins